Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of generic ticagrelor 90 mg vs Brilinta 90 mg under fasting conditions in healthy Thai volunteers
TCTR20231002009Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ticagrelor in cardiac morbidity (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on TCTR20231002009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231002009.